Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A study at Oxford University Hospitals (OUH) NHS Foundation Trust has revealed the different levels of risk faced by healthcare workers dealing with the COVID-19 pandemic.

Outside the John Radcliffe Hospital

In a major collaboration with the University of Oxford, almost 10,000 staff were tested both for presence of the virus responsible for COVID-19 and antibodies to the virus. In combination these tests give an accurate view of who has had coronavirus infection to date in the OUH workforce.

There have been many studies looking at COVID-19 in healthcare workers, but this study, released today in a medRxiv preprint, is the first to comprehensively investigate all staff groups across an institution, and combines data from both symptomatic and asymptomatic staff testing programmes. The programme was able to 

  • identify and isolate staff members who had the infection before they developed symptoms, preventing them passing infection on to other staff and patients
  • identify in which areas of the hospital staff were at greatest risk 
  • identify which staff groups were at greatest risk 
  • record which staff have antibodies to the virus that causes COVID-19, enabling these staff to be monitored to understand if these antibodies provide immunity against repeat infections.

Based on the findings of the testing, OUH was able to implement an infection prevention and control plan to limit transmission of the virus.

The full story is available on the Oxford University Hospitals (OUH) NHS Foundation Trust website

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology

The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.